Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
Our top-notch dedicated system is used to design specialised libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The method includes detailed molecular simulations of the catalytic and allosteric binding pockets, along with ensemble virtual screening that considers their conformational flexibility. In the design of modulators, structural changes induced by reaction intermediates are taken into account to enhance activity and selectivity.
Our library stands out due to several important features:
partner
Reaxense
upacc
Q9Y680
UPID:
FKBP7_HUMAN
Alternative names:
23 kDa FK506-binding protein; FK506-binding protein 7; Rotamase
Alternative UPACC:
Q9Y680; Q4ZG70; Q6V3B2; Q86U65; Q96DA4; Q9Y6B0
Background:
Peptidyl-prolyl cis-trans isomerase FKBP7, also known as 23 kDa FK506-binding protein, FK506-binding protein 7, and Rotamase, plays a crucial role in protein synthesis. It accelerates the folding of proteins, a fundamental process for cellular function and integrity.
Therapeutic significance:
Understanding the role of Peptidyl-prolyl cis-trans isomerase FKBP7 could open doors to potential therapeutic strategies. Its pivotal function in protein folding highlights its importance in maintaining cellular health and presents an opportunity for drug discovery.